Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(40%)
Results Posted
50%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_1
1
20%
Ph not_applicable
1
20%
Ph phase_4
3
60%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Active, not recruiting1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 43 (60.0%)
N/A1 (20.0%)

Trials by Status

active_not_recruiting120%
terminated120%
completed240%
recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
terminatedphase_4

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

NCT04973007
recruitingphase_4

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

NCT04373564
active_not_recruitingnot_applicable

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

NCT02156739
completedphase_4

Eovist vs. Dotarem Healthy Volunteer MRI

NCT02431598
completedphase_1

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

NCT02578602

Clinical Trials (5)

Showing 5 of 5 trials
NCT04973007Phase 4

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

Terminated
NCT04373564Phase 4

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Recruiting
NCT02156739Not Applicable

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

Active Not Recruiting
NCT02431598Phase 4

Eovist vs. Dotarem Healthy Volunteer MRI

Completed
NCT02578602Phase 1

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5